VRCAHealthcareNano-Cap

Verrica Pharmaceuticals Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for Verrica Pharmaceuticals Inc. (VRCA), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are VRCA insiders buying or selling?

Verrica Pharmaceuticals Inc. insiders reported 48 open-market buys ($80.6M) and 74 sells ($8.2M) across 122 Form 4 filings — a net buying position of $72.4M.

Source: SEC EDGAR Form 4

Key Statistics (as of Nov 26, 2025)

Total Form 4 filings
122
SEC EDGAR
Insider filers
17
Insider buys (48)
$80.6M
Insider sells (74)
$8.2M

Insider sentiment

Net buying

Net insider flow of $72.4M in net buying.

Recent VRCA insider transactions

DateInsiderRoleTypeSharesPriceValue
Nov 26, 2025Noah L. RosenbergCMOPurchase2.4K$4.24$10.0K
Nov 26, 2025John J. KirbyInterim CFOPurchase3.5K$4.24$15.0K
Nov 26, 2025David ZawitzChief Operating OfficerPurchase10.0K$4.24$42.4K
Nov 26, 2025Jayson RiegerCEO and PresidentPurchase94.3K$4.24$400.1K
Nov 26, 2025Manning Paul BDirector, 10% OwnerPurchase4.1M$4.24$17.5M
Mar 18, 2025Christopher G. HayesCHIEF LEGAL OFFICERSale4.3K$0.65$2.8K
Nov 26, 2024Jayson RiegerCEO and PresidentPurchase280.9K$0.00$0
Nov 26, 2024John A Stalfort IIIDirectorPurchase1.1M$0.00$0
Nov 26, 2024Manning Paul BDirector, 10% OwnerPurchase22.9M$0.00$0
Aug 28, 2024Christopher G. HayesCHIEF LEGAL OFFICERSale35.7K$2.61$93.1K
Aug 28, 2024Gary GoldenbergChief Medical OfficerSale13.5K$2.61$35.2K
Aug 28, 2024Joe BonaccorsoCHIEF COMMERCIAL OFFICERSale33.7K$2.61$87.8K
Aug 28, 2024Terry KohlerCHIEF FINANCIAL OFFICERSale29.7K$2.61$77.5K
Aug 28, 2024Ted WhitePRESIDENT AND CEOSale34.0K$2.61$88.6K
Jul 23, 2024Ted WhitePRESIDENT AND CEOSale32.6K$7.06$230.3K
Jul 23, 2024Joe BonaccorsoCHIEF COMMERCIAL OFFICERSale25.6K$7.06$180.6K
Jul 23, 2024Gary GoldenbergChief Medical OfficerSale18.5K$7.06$130.7K
Jul 23, 2024Christopher G. HayesCHIEF LEGAL OFFICERSale21.7K$7.06$153.5K
Dec 29, 2023Joseph Edelman10% OwnerPurchase321.6K$7.17$2.3M
Dec 27, 2023Joseph Edelman10% OwnerPurchase504.7K$6.45$3.3M
Dec 19, 2023Joseph Edelman10% OwnerPurchase1.2M$5.63$6.9M
Nov 16, 2023Joe BonaccorsoChief Commercial OfficerSale32.8K$2.94$96.7K
Nov 16, 2023Gary GoldenbergChief Medical OfficerSale8.9K$2.94$26.1K
Nov 16, 2023Terry KohlerChief Financial OfficerSale28.1K$2.94$82.7K
Nov 16, 2023Ted WhitePresident and CEOSale33.7K$2.94$99.2K

Showing the 25 most recent of 122 Form 4 filings for Verrica Pharmaceuticals Inc..

Most active VRCA insiders

  • Matt Davidson55 filings
  • Manning Paul B15 filings
  • Ted White11 filings
  • Christopher G. Hayes8 filings
  • Gary Goldenberg5 filings

Ask anything about VRCA insider activity

Use Trabud's AI agent to query Verrica Pharmaceuticals Inc.'s Form 4 history in plain English — "Show me VRCA CEO purchases this year" or compare it against any other ticker.

Open the AI agent

VRCA insider trading FAQ

Are Verrica Pharmaceuticals Inc. insiders buying or selling?

Across 122 SEC Form 4 filings, Verrica Pharmaceuticals Inc. (VRCA) insiders reported 48 open-market purchases totaling $80.6M and 74 sales totaling $8.2M. That is a net buying position of $72.4M.

How many insiders trade VRCA stock?

17 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Verrica Pharmaceuticals Inc.. The most recent filing was accepted on Nov 26, 2025.

Where does Trabud get VRCA insider trading data?

All VRCA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content